Evidence map›Paper›PMID 36381071›Full record

ArticleJournal of medical biochemistry2022

Evaluation of amino acid profile in serum of patients with Covid-19 for providing a new treatment strategy.

Ali Ozturk, Nihayet Bayraktar, Mustafa Bayraktar, Bashar Ibrahim, Taylan Bozok, Ceylan Mehmet Resat

Open access · diamondAbstract read
In one paragraph

Article in Journal of medical biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Comparative urinary metabolomics reveals unique and shared pathways in COVID-19 and liver diseases.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Ali OzturkNiğde Omer Halisdemir University, Faculty of Medicine, Department of Medical Microbiology, Niğde, Turkey.
Nihayet BayraktarHarran University, Faculty of Medicine, Department of Medical Biochemistry, Şanlıurfa, Turkey.
Mustafa BayraktarYıdırım Beyazıt University, Faculty of Medicine, Department of Internal Medical, Ankara, Turkey.
Bashar IbrahimSuleyman Demirel Universit, Faculty of Pharmacy Department of Pharmaceutical Microbiology, Isparta, Turkey.
Taylan BozokMersin University, Faculty of Medicine, Department of Medical Microbiology, Mersin, Turkey.
Ceylan Mehmet ResatHarran University, Faculty of Medicine, Department of Infectious Diseases, Şanlıurfa, Turkey.
Harran University · TRAnkara Yıldırım Beyazıt University · TRMersin Üniversitesi · TRNiğde Ömer Halisdemir Üniversitesi · TRSüleyman Demirel University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Amino acids have an important role in metabolism and may affect COVID-19-related outcomes. In our study, the amino acid serum level of hospitalized COVID19 patients was evaluated to determine a new treatment strategy. Methods: The amino acid profile covering 43 amino acids in 68 subjects, comprising 30 (14 men and 16 women) controls and 38 (16 men and 22 women) COVID-19 patients, were examined. The amino acid profiles of the participants were screened by LC-MS/MS. Results: Compared with the control group, serum levels of 27 amino acids increased in the patient group. Alpha-aminopimelic acid, sarcosine, and hydroxyproline amino acids were considerably higher in the control group than in the patient group (p<0.0001). There was no notable difference among control group and the case group for 13 amino acids (p≥0.05). A significant positive correlation was seen among the control and the patient groups in the mean amino acid values (r=0.937; p<0.0001). Conclusions: These results postulated a clear picture on the serum levels of amino acid in the COVID-19 patients. Serum amino acids measured in hospitalized COVID-19 patients can explain the patient's metabolic status during the disease.

Indexed as

amino acidCovid-19Sars-CoV-2treatment strategy

Identifiers

PMID36381071
PMCPMC9618340
OpenAlexW4286457298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.